Impact of Antenatal Corticosteroids on Cortisol and Glucose Homeostasis Levels in Preterm Neonates: A Meta-Analysis

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Dec 30

PMID 39735060

Authors

Prerana S Bharadwaj

Srikrishna V Acharya

Affiliations

Soon will be listed here.

Abstract

Antenatal corticosteroids (ACS) are widely used to reduce respiratory distress syndrome (RDS) in preterm neonates, enhancing neonatal outcomes. However, the potential effects of ACS on other aspects of neonatal health, such as cortisol levels and glucose regulation, remain a concern. This study examines whether ACS administration impacts cortisol and glucose homeostasis in preterm infants by analyzing data from 14 selected studies. Using a random-effects model, we found no significant impact of ACS on cortisol levels (mean differences (MD) 2.23, confidence interval (CI) 5.26 to -0.80) or blood glucose levels (standard mean differences (SMD) 0.18, CI 0.00 to 0.35). Additionally, there was no notable difference in hypoglycemia risk between groups receiving ACS and those unexposed (odds ratio (OR) 1.46, CI 0.99 to 2.17). Subgroup and sensitivity analyses reinforced these findings, underscoring their robustness, and risk-of-bias assessment confirmed a low risk across the included studies. Our findings support the safety of ACS for cortisol and glucose levels in preterm infants, affirming its continued use for lung development while recommending vigilant blood glucose monitoring to manage potential hypoglycemia. These results provide essential insights for neonatal care protocols, contributing to the overall welfare of premature infants.

References

Schacke H, Docke W, Asadullah K . Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther. 2002; 96(1):23-43. DOI: 10.1016/s0163-7258(02)00297-8. View

Karlsson R, Kallio J, Toppari J, Scheinin M, Kero P . Antenatal and early postnatal dexamethasone treatment decreases cortisol secretion in preterm infants. Horm Res. 2000; 53(4):170-6. DOI: 10.1159/000023563. View

Ekhaguere O, Okonkwo I, Batra M, Hedstrom A . Respiratory distress syndrome management in resource limited settings-Current evidence and opportunities in 2022. Front Pediatr. 2022; 10:961509. PMC: 9372546. DOI: 10.3389/fped.2022.961509. View

Teramo K, Hallman M, Raivio K . Maternal glucocorticoid in unplanned premature labor. Controlled study on the effects of betamethasone phosphate on the phospholipids of the gastric aspirate and on the adrenal cortical function of the newborn infant. Pediatr Res. 1980; 14(4 Pt 1):326-9. DOI: 10.1203/00006450-198004000-00013. View

Srivastava T, Merchant R, Ambadekar M . Cord blood cortisol levels and respiratory distress syndrome. Indian Pediatr. 1994; 31(8):923-8. View

Amawat J, Wirayannawat W, Boonyanunt P, Paes B, Kitsommart R . Effects of antenatal dexamethasone on postnatal serum cortisol levels in late preterm infants. J Matern Fetal Neonatal Med. 2023; 36(2):2224491. DOI: 10.1080/14767058.2023.2224491. View

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021; 10(1):89. PMC: 8008539. DOI: 10.1186/s13643-021-01626-4. View

Patsopoulos N, Evangelou E, Ioannidis J . Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol. 2008; 37(5):1148-57. PMC: 6281381. DOI: 10.1093/ije/dyn065. View

Uquillas K, Lee R, Sardesai S, Chen E, Ihenacho U, Cortessis V . Neonatal hypoglycemia after initiation of late preterm antenatal corticosteroids. J Perinatol. 2020; 40(9):1339-1348. DOI: 10.1038/s41372-020-0589-1. View

10.

Aucott S, Watterberg K, Shaffer M, Donohue P . Early cortisol values and long-term outcomes in extremely low birth weight infants. J Perinatol. 2009; 30(7):484-8. PMC: 3586211. DOI: 10.1038/jp.2009.191. View

11.

Khanimov I, Boaz M, Shimonov M, Wainstein J, Leibovitz E . Systemic Treatment With Glucocorticoids Is Associated With Incident Hypoglycemia and Mortality: A Historical Prospective Analysis. Am J Med. 2020; 133(7):831-838.e1. DOI: 10.1016/j.amjmed.2019.12.026. View

12.

Uno H, Eisele S, Sakai A, Shelton S, Baker E, DeJesus O . Neurotoxicity of glucocorticoids in the primate brain. Horm Behav. 1994; 28(4):336-48. DOI: 10.1006/hbeh.1994.1030. View

13.

Ogueh O, Miell J, Jones J, Jones J, Alaghband-Zadeh J, Johnson M . Antenatal dexamethasone and the growth hormone-insulin-like growth factor axis. Hum Reprod. 2000; 15(6):1403-6. DOI: 10.1093/humrep/15.6.1403. View

14.

Weiss S, Niemann S . Effects of Antenatal Corticosteroids on Cortisol and Heart Rate Reactivity of Preterm Infants. Biol Res Nurs. 2015; 17(5):487-94. DOI: 10.1177/1099800414564860. View

15.

Ryu Y, Oh S, Sohn J, Lee J . The Associations between Antenatal Corticosteroids and In-Hospital Outcomes of Preterm Singleton Appropriate for Gestational Age Neonates according to the Presence of Maternal Histologic Chorioamnionitis. Neonatology. 2019; 116(4):369-375. DOI: 10.1159/000502650. View

16.

Norberg H, Stalnacke J, Nordenstrom A, Norman M . Repeat antenatal steroid exposure and later blood pressure, arterial stiffness, and metabolic profile. J Pediatr. 2013; 163(3):711-6. DOI: 10.1016/j.jpeds.2013.03.074. View

17.

Usuda H, Fee E, Carter S, Furfaro L, Takahashi T, Takahashi Y . Low-dose antenatal betamethasone treatment achieves preterm lung maturation equivalent to that of the World Health Organization dexamethasone regimen but with reduced endocrine disruption in a sheep model of pregnancy. Am J Obstet Gynecol. 2022; 227(6):903.e1-903.e16. DOI: 10.1016/j.ajog.2022.06.058. View

18.

Kim W, Han Y, Ko H, Park I, Shin J, Wie J . Antenatal corticosteroids and outcomes of preterm small-for-gestational-age neonates in a single medical center. Obstet Gynecol Sci. 2018; 61(1):7-13. PMC: 5780323. DOI: 10.5468/ogs.2018.61.1.7. View

19.

Valencia G, Rojas V . Association between antenatal steroids for lung maturation and hypoglycaemia in the first 48 hours in premature infants between 26 and 34 weeks of gestational age. Pediatr Endocrinol Diabetes Metab. 2020; 25(4):177-182. DOI: 10.5114/pedm.2019.89639. View

20.

McDougall A, Aboud L, Lavin T, Cao J, Dore G, Ramson J . Effect of antenatal corticosteroid administration-to-birth interval on maternal and newborn outcomes: a systematic review. EClinicalMedicine. 2023; 58:101916. PMC: 10050784. DOI: 10.1016/j.eclinm.2023.101916. View